Tender detail
Medicine rebate agreements for fluorouracil and its combinations
Summary
The procurement concerns non-exclusive rebate agreements for medicines containing the active ingredient fluorouracil, alone or in combination with other ingredients. Agreements may be concluded at any time under the open-house model for the period from 1 January 2027 to 31 December 2028. Medicines on the BfArM list of children’s medicines are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.